$BLFS
BIOLIFE SOLUTIONS INC Stock $blfs

$blfs Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000143774923013777 Filed on May 11, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$39.51M	$37.70M
YoY Change	-2.53%	4.09%
Cost Of Revenue	$27.70M	$23.66M
YoY Change	-71.18%	-3.2%
Gross Profit	$11.81M	$14.04M
YoY Change	-121.26%	19.24%
Gross Profit Margin	29.9%	37.24%
Selling, General & Admin	$21.72M	$21.31M
YoY Change	29.55%	32.49%
% of Gross Profit	183.88%	151.81%
Research & Development	$4.840M	$4.152M
YoY Change	41.19%	9.81%
% of Gross Profit	40.98%	29.57%
Depreciation & Amortization	$1.000M	$1.721M
YoY Change	-77.61%	4.11%
% of Gross Profit	8.47%	12.26%
Operating Expenses	$26.56M	$25.47M
YoY Change	28.33%	28.17%
Operating Profit	-$15.28M	-$13.61M
YoY Change	-79.96%	78.24%
Interest Expense	-$419.0K	-$411.0K
YoY Change	4555.56%	152.15%
% of Operating Profit
Other Income/Expense, Net	$5.086M	-$17.00K
YoY Change	-23218.18%	-46.88%
Pretax Income	-$10.19M	-$13.62M
YoY Change	-86.64%	77.72%
Income Tax	$5.000K	$92.00K
% Of Pretax Income
Net Earnings	-$10.20M	-$13.71M
YoY Change	-85.94%	94.08%
Net Earnings / Revenue	-25.82%	-36.37%
Basic Earnings Per Share	-$0.23	-$0.32
Diluted Earnings Per Share	-$0.23	-$0.32
COMMON SHARES
Basic Shares Outstanding	43.46M	43.21M
Diluted Shares Outstanding	43.44M shares	43.03M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$46.26M	$54.89M
YoY Change	92.73%	-7.7%
Cash & Equivalents	$21.40M	$19.11M
Short-Term Investments	$24.86M	$35.78M
Other Short-Term Assets	$32.87M	$42.01M
YoY Change	11.57%	781.31%
Inventory	$39.18M	$41.33M
Prepaid Expenses
Receivables	$26.86M	$30.34M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$120.3M	$132.8M
YoY Change	1.91%	11.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$25.57M	$26.10M
YoY Change	-44.27%	42.94%
Goodwill	$224.7M	$224.7M
YoY Change		0.0%
Intangibles	$29.18M	$30.63M
YoY Change		-79.48%
Long-Term Investments	$5.069M	$5.069M
YoY Change	15.94%	15.94%
Other Assets	$2.155M	$2.303M
YoY Change	165.39%	769.06%
Total Long-Term Assets	$312.9M	$313.7M
YoY Change	-11.2%	-26.25%
TOTAL ASSETS
Total Short-Term Assets	$120.3M	$132.8M
Total Long-Term Assets	$312.9M	$313.7M
Total Assets	$433.2M	$446.5M
YoY Change	-7.91%	-17.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.69M	$15.53M
YoY Change	-7.38%	32.57%
Accrued Expenses	$3.673M	$3.825M
YoY Change	-61.29%	178.79%
Deferred Revenue	$385.0K	$422.0K
YoY Change		-52.85%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.935M	$1.250M
YoY Change	27.64%	124.42%
Total Short-Term Liabilities	$39.59M	$47.32M
YoY Change	18.89%	35.04%
LONG-TERM LIABILITIES
Long-Term Debt	$23.57M	$23.69M
YoY Change	268.25%	275.29%
Other Long-Term Liabilities	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Total Long-Term Liabilities	$23.57M	$23.69M
YoY Change	-0.2%	271.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$39.59M	$47.32M
Total Long-Term Liabilities	$23.57M	$23.69M
Total Liabilities	$81.05M	$88.36M
YoY Change	39.58%	34.92%
SHAREHOLDERS EQUITY
Retained Earnings	-$270.8M	-$260.6M
YoY Change	44.51%	132.53%
Common Stock	$623.5M	$619.3M
YoY Change		4.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$352.1M	$358.1M
YoY Change
Total Liabilities & Shareholders Equity	$433.2M	$446.5M
YoY Change	-7.91%	-17.93%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$10.20M	-$13.71M
YoY Change	-85.94%	94.08%
Depreciation, Depletion And Amortization	$1.000M	$1.721M
YoY Change	-77.61%	4.11%
Cash From Operating Activities	-$7.718M	-$2.712M
YoY Change	-22.17%	-65.77%
INVESTING ACTIVITIES
Capital Expenditures	$2.160M	$3.295M
YoY Change	-208.27%	126.3%
Acquisitions
YoY Change
Other Investing Activities	$11.45M	$7.222M
YoY Change	-149.63%
Cash From Investing Activities	$9.292M	$2.926M
YoY Change	-137.06%	-228.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	704.0K	-$562.0K
YoY Change	-343.6%	210.5%
NET CHANGE
Cash From Operating Activities	-7.718M	-$2.712M
Cash From Investing Activities	9.292M	$2.926M
Cash From Financing Activities	704.0K	-$562.0K
Net Change In Cash	2.278M	-$348.0K
YoY Change	-106.46%	-96.65%
FREE CASH FLOW
Cash From Operating Activities	-$7.718M	-$2.712M
Capital Expenditures	$2.160M	$3.295M
Free Cash Flow	-$9.878M	-$6.007M
YoY Change	24.69%	-35.96%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	BIOLIFE SOLUTIONS INC
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000834365
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	956000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	739000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43289969
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43289969
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42832231
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42832231
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	32088000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	224741000	usd
CY2023Q1	dei	Entity File Number EntityFileNumber	001-36362
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	94-3076866
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	3303 Monte Villa Parkway, Suite 310
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Bothell
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	98021
CY2023Q1	dei	City Area Code CityAreaCode	425
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	402-1400
CY2023Q1	dei	Security12b Title Security12bTitle	BioLife Solutions, Inc. Common Stock
CY2023Q1	dei	Trading Symbol TradingSymbol	BLFS
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	43456275
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19105000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19442000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	31000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	31000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	35780000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	43260000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	30343000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	33936000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	41329000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	34904000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6201000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6879000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	132789000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	138452000	usd
CY2023Q1	blfs	Assets Held For Rent Noncurrent AssetsHeldForRentNoncurrent	9005000	usd
CY2022Q4	blfs	Assets Held For Rent Noncurrent AssetsHeldForRentNoncurrent	9064000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	26100000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23638000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15592000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15292000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	242000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	272000	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	284000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	281000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Noncurrent DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossNoncurrent	2019000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Noncurrent DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossNoncurrent	1332000	usd
CY2023Q1	blfs	Investments In Non Marketable Equity Securities And Available For Sale Debt Securities InvestmentsInNonMarketableEquitySecuritiesAndAvailableForSaleDebtSecurities	5069000	usd
CY2022Q4	blfs	Investments In Non Marketable Equity Securities And Available For Sale Debt Securities InvestmentsInNonMarketableEquitySecuritiesAndAvailableForSaleDebtSecurities	5069000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	30629000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14842000	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	256000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	224741000	usd
CY2023Q1	us-gaap	Assets Assets	446470000	usd
CY2022Q4	us-gaap	Assets Assets	450229000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	15525000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	15367000	usd
CY2023Q1	blfs	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	10701000	usd
CY2022Q4	blfs	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	9782000	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	4585000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	4151000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	8895000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	8312000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2906000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2860000	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	161000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	158000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1250000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1814000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	3296000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	2138000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	47319000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	44582000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	1880000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	2318000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	15114000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	14962000	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	95000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	126000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	23692000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	23793000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	263000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	250000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	88363000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	86041000	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	43000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	43000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	619227000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	611739000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-534000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-679000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-260629000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-246915000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	358107000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	364188000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	446470000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	450229000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	37703000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	36220000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11530000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6471000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2863000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4891000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4152000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3781000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1459000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1721000	usd
CY2022Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	11000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	720000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-3335000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	51308000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	44187000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-13605000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7967000	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-411000	usd
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-184000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	394000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	131000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-17000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-53000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13622000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8020000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	92000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-599000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-13714000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7421000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13714000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7421000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43027612
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42014055
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-13714000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7421000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	106000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-156000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	39000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13569000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7577000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	364188000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7363000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	125000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	106000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	39000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-13714000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	358107000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	478047000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	51000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5399000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	257000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-156000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7421000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	476075000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-13714000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7421000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1653000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1459000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2863000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	13000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7363000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5399000	usd
CY2023Q1	blfs	Noncash Lease Expense NoncashLeaseExpense	418000	usd
CY2022Q1	blfs	Noncash Lease Expense NoncashLeaseExpense	524000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	13000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-599000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	720000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-3335000	usd
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	390000	usd
CY2022Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-0	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-68000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-18000	usd
CY2023Q1	blfs	Gain Loss On Disposition Of Assets Held For Rent GainLossOnDispositionOfAssetsHeldForRent	-218000	usd
CY2022Q1	blfs	Gain Loss On Disposition Of Assets Held For Rent GainLossOnDispositionOfAssetsHeldForRent	96000	usd
CY2023Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-50000	usd
CY2022Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-17000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3612000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1083000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6425000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1855000	usd
CY2023Q1	blfs	Increase Decrease In Prepaid Expense Other Current Assets And Longterm Deposits IncreaseDecreaseInPrepaidExpenseOtherCurrentAssetsAndLongtermDeposits	-661000	usd
CY2022Q1	blfs	Increase Decrease In Prepaid Expense Other Current Assets And Longterm Deposits IncreaseDecreaseInPrepaidExpenseOtherCurrentAssetsAndLongtermDeposits	1213000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	157000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3231000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	371000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1074000	usd
CY2023Q1	blfs	Increase Decrease In Warranty Liability IncreaseDecreaseInWarrantyLiability	583000	usd
CY2022Q1	blfs	Increase Decrease In Warranty Liability IncreaseDecreaseInWarrantyLiability	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	510000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	1543000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-20000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2712000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7924000	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	8202000	usd
CY2022Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	-0	usd
CY2023Q1	blfs	Proceeds From Sale Of Marketable Securities ProceedsFromSaleOfMarketableSecurities	524000	usd
CY2022Q1	blfs	Proceeds From Sale Of Marketable Securities ProceedsFromSaleOfMarketableSecurities	0	usd
CY2023Q1	blfs	Proceeds From Maturity Of Marketable Securities ProceedsFromMaturityOfMarketableSecurities	14900000	usd
CY2022Q1	blfs	Proceeds From Maturity Of Marketable Securities ProceedsFromMaturityOfMarketableSecurities	0	usd
CY2023Q1	blfs	Payments To Acquire Assets Held For Rent PaymentsToAcquireAssetsHeldForRent	1001000	usd
CY2022Q1	blfs	Payments To Acquire Assets Held For Rent PaymentsToAcquireAssetsHeldForRent	814000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3295000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1456000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2926000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2270000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	125000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	257000	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	-0	usd
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	50000	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	9000	usd
CY2022Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	42000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-562000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-181000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-348000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7421000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-10375000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19473000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	69870000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-22000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19136000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	59473000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	347000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	13000	usd
CY2023Q1	blfs	Noncash Or Part Noncash Acquisition Equipment Acquired Under Operating Leases NoncashOrPartNoncashAcquisitionEquipmentAcquiredUnderOperatingLeases	880000	usd
CY2022Q1	blfs	Noncash Or Part Noncash Acquisition Equipment Acquired Under Operating Leases NoncashOrPartNoncashAcquisitionEquipmentAcquiredUnderOperatingLeases	243000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-39000	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	0	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	497000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	91000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	56900000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	64100000	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5024000	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	118968000	usd
CY2022Q1	us-gaap	Assets Assets	544279000	usd
CY2022Q1	blfs	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	6733000	usd
CY2022Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	2945000	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	37752000	usd
CY2022Q1	us-gaap	Liabilities Liabilities	68204000	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-114531000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	476075000	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	544279000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11530000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	44187000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7967000	usd
CY2022Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-184000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-53000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8020000	usd
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7421000	usd
CY2022Q1	blfs	Increase Decrease In Prepaid Expense Other Current Assets And Longterm Deposits IncreaseDecreaseInPrepaidExpenseOtherCurrentAssetsAndLongtermDeposits	1213000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	8274000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	41329000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	1543000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	720	usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	-3335	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	35792000	usd
CY2023Q1	blfs	Debt Securities Availableforsale Unrealized Gain Current DebtSecuritiesAvailableforsaleUnrealizedGainCurrent	7000	usd
CY2023Q1	blfs	Debt Securities Availableforsale Unrealized Loss Current DebtSecuritiesAvailableforsaleUnrealizedLossCurrent	19000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	35780000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	37810000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	9000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	20000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	37799000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	35792000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	35780000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Noncurrent DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent	2018000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	2019000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	37810000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	37799000	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	23682000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	20950000	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6934000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	5680000	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	10713000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	34904000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9623000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2773000	usd
CY2023Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	13000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.043	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.042	pure
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.061	pure
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.061	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y10M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y2M12D
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M18D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	897000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	913000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	402000	usd
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	565000	usd
CY2023Q1	blfs	Operating Lease Costs And Shortterm Lease Costs OperatingLeaseCostsAndShorttermLeaseCosts	1299000	usd
CY2022Q1	blfs	Operating Lease Costs And Shortterm Lease Costs OperatingLeaseCostsAndShorttermLeaseCosts	1478000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	259000	usd
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	305000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	1558000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	1783000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2690000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	128000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3398000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	101000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2954000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	38000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2533000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	2000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2280000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	usd
CY2023Q1	blfs	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	6938000	usd
CY2023Q1	blfs	Finance Lease Liability Payments Due After Year Four FinanceLeaseLiabilityPaymentsDueAfterYearFour	0	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	20793000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	269000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	18020000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9171000	usd
CY2023Q1	blfs	Shippers Placed In Service Gross ShippersPlacedInServiceGross	8132000	usd
CY2022Q4	blfs	Shippers Placed In Service Gross ShippersPlacedInServiceGross	7671000	usd
CY2023Q1	blfs	Fixed Assets Held For Rent FixedAssetsHeldForRent	4686000	usd
CY2022Q4	blfs	Fixed Assets Held For Rent FixedAssetsHeldForRent	4686000	usd
CY2023Q1	blfs	Shippers Placed In Service Accumulated Depreciation ShippersPlacedInServiceAccumulatedDepreciation	5451000	usd
CY2022Q4	blfs	Shippers Placed In Service Accumulated Depreciation ShippersPlacedInServiceAccumulatedDepreciation	4952000	usd
CY2023Q1	blfs	Shippers Placed In Service Net ShippersPlacedInServiceNet	7367000	usd
CY2022Q4	blfs	Shippers Placed In Service Net ShippersPlacedInServiceNet	7405000	usd
CY2023Q1	blfs	Shippers And Related Components In Production ShippersAndRelatedComponentsInProduction	1638000	usd
CY2022Q4	blfs	Shippers And Related Components In Production ShippersAndRelatedComponentsInProduction	1659000	usd
CY2023Q1	blfs	Shippers Placed In Service And Fixed Assets Held For Rent Net ShippersPlacedInServiceAndFixedAssetsHeldForRentNet	9005000	usd
CY2022Q4	blfs	Shippers Placed In Service And Fixed Assets Held For Rent Net ShippersPlacedInServiceAndFixedAssetsHeldForRentNet	9064000	usd
CY2023Q1	blfs	Assets Held For Rent Depreciation AssetsHeldForRentDepreciation	843000	usd
CY2022Q1	blfs	Assets Held For Rent Depreciation AssetsHeldForRentDepreciation	896000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	35723000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	32809000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	26100000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23638000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	878000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	757000	usd
CY2023Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	54098000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	23469000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	30629000	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	54098000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	22010000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	32088000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1500000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2900000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	3972000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	4607000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4435000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4137000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3383000	usd
CY2023Q1	blfs	Finitelived Intangible Asset Expected Amortization After Year Four FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour	10095000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	30629000	usd
CY2023Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	5306000	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	5080000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3825000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3128000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	422000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	548000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1148000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	975000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	0	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	51000	usd
CY2023Q1	blfs	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	10701000	usd
CY2022Q4	blfs	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	9782000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	8312000	usd
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	9398000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1891000	usd
CY2022Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1419000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1308000	usd
CY2022Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1641000	usd
CY2023Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	8895000	usd
CY2022Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	9176000	usd
CY2022Q1	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	525000	usd
CY2023Q1	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	4400000	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	3700000	usd
CY2023Q1	blfs	Sales Taxes Assessed SalesTaxesAssessed	230000	usd
CY2022	blfs	Sales Taxes Assessed SalesTaxesAssessed	306000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	25091000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	25786000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	149000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	179000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	24942000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	25607000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1250000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1814000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	1135000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	5481000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	10511000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	5219000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	2596000	usd
CY2023Q1	blfs	Longterm Debt Maturity After Year Four LongtermDebtMaturityAfterYearFour	0	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	24942000	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	422000	usd
CY2022Q1	us-gaap	Deferred Revenue DeferredRevenue	558000	usd
CY2023Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	242000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	37703000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	36220000	usd
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42014055
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7363000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5399000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-92000000000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.007	pure
	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	505000	usd
	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	1.1	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	40100000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-13714000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7421000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13714000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7421000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43027612
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3153029
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2094863

Files In Submission

Name	View Source	Status
blfs-20230331_lab.xml	Edgar Link	unprocessable
blfs-20230331_cal.xml	Edgar Link	unprocessable
0001437749-23-013777-index-headers.html	Edgar Link	pending
0001437749-23-013777-index.html	Edgar Link	pending
0001437749-23-013777.txt	Edgar Link	pending
0001437749-23-013777-xbrl.zip	Edgar Link	pending
bioli20230331_10q.htm	Edgar Link	pending
blfs-20230331.xsd	Edgar Link	pending
bioli20230331_10q_htm.xml	Edgar Link	completed
ex_518009.htm	Edgar Link	pending
ex_518010.htm	Edgar Link	pending
ex_518011.htm	Edgar Link	pending
ex_518012.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
logo.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
blfs-20230331_def.xml	Edgar Link	unprocessable
blfs-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BLFS
BIOLIFE SOLUTIONS INC Stock $blfs

2023 Q2 Form 10-Q Financial Statement

#000143774923013777 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLFS BIOLIFE SOLUTIONS INC Stock $blfs

2023 Q2 Form 10-Q Financial Statement

#000143774923013777 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLFS
BIOLIFE SOLUTIONS INC Stock $blfs